U.S. markets closed

Walgreens Boots Alliance, Inc. (WBA)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
48.31-0.15 (-0.31%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close48.46
Open48.64
Bid48.31 x 1200
Ask48.29 x 1800
Day's Range48.24 - 48.67
52 Week Range33.36 - 57.05
Volume3,457,419
Avg. Volume5,677,540
Market Cap41.788B
Beta (5Y Monthly)0.48
PE Ratio (TTM)18.26
EPS (TTM)2.64
Earnings DateOct 14, 2021
Forward Dividend & Yield1.91 (3.95%)
Ex-Dividend DateAug 19, 2021
1y Target Est52.09
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
-19% Est. Return
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Walgreens Boots Alliance, Inc.
    Analyst Report: Walgreens Boots Alliance, Inc.Walgreens Boots Alliance is a leading retail pharmacy chain, with over 21,000 stores in 50 states and 11 countries. Walgreens’ core strategy involves brick-and-mortar retail pharmacy locations in high-traffic areas, with nearly 80% of the U.S. population living within 5 miles of a store. Currently, the company has a leading market share of the domestic prescription drug market at about 20%. In 2021, the company sold off a majority of its Alliance Healthcare wholesale business to AmerisourceBergen for $6.5 billion, doubling down on its core pharmacy efforts and ventures in strategic growth areas in primary care (VillageMD) and digital offerings. The company also has equity stakes in AmerisourceBergen (29%) and Sinopharm Holding Guoda Drugstores (40%).
    Rating
    Fair Value
    Economic Moat
    4 days agoMorningstar
View more